Our Collab Network members are not only experts within their own domain but educators with the research community. Learn more about the discoveries and findings our collaborators are achieving with IDT.
The future of personalized genomics
Manja Meggendorfer is the Head of Molecular Genetics at Munich Leukemia Laboratory (MLL), where she oversees various R&D activities such as the 5,000 genome project, which is aimed at better understanding the genetic factors behind leukemia. She received her Master of Science in Biology from the Ludwig-Maximilians-University in Munich and her PhD. in collaboration with the Helmholtz Center Munich working on gene regulation within the architecture of the cell nucleus. After her post-doctorate, she moved to the field of hematology as a scientist in the department of molecular genetics at MLL. In combination with her MBA in Health Care Management, Manja hopes to improve the diagnostic and prognostic work associated with routine diagnostic approaches for leukemia or lymphoma patients.
Developing genomic sequencing assays for infectious disease surveillance
Nikki Freed is the Lead Technologist at Auckland Genomics at the University of Auckland, New Zealand. For six years, she was a lecturer and senior lecturer at the School of Natural and Computational Sciences at Massey University, Auckland. Nikki completed her PhD at ETH Zurich in Switzerland and worked for three years at Novartis Pharmaceuticals in Basel, Switzerland. Nikki helped design successful methods for whole genome sequencing of SARS-CoV-2.
The featured content pieces below provide insight into Nikki’s thoughts on the SARS-CoV-2 pandemic and the future of infectious disease surveillance. Click on them to learn more!